CLYM vs COF · $85.8M cap vs P/E 62, rev $53.43B
Climb Bio Inc (CLYM) versus Capital One Financial Corporation (COF) — a side-by-side from cached financials, not a winner call.
Climb Bio Inc (CLYM) is a biotechnology company listed on US.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
CLYM does not have a complete income-statement cache yet.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
CLYM currently screens at market cap $85.8M. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Not investment advice. Open the CLYM and COF stock pages for the full models.
Not investment advice.